In this issue:
Catecholaminergic drugs useful in depression resistant to SSRIs
Persistent poor sleep linked to adverse health outcomes
Genotype for olanzapine/fluoxetine response?
Mortality associated with depression following MI
Inflammation fails to predict antidepressant response in CHD
Antidepressants: perseverance pays off
Anhedonia and recovery in SSRI-resistant depression
Antidepressant augmentation with rTMS
Ketamine as a novel antidepressant
Please login below to download this issue (PDF)